All In Biotech

Drug Trial Radar · NCT00439413

Selegiline for Smoking Cessation - 1

Phase 2, Double-Blind, Placebo-Controlled Trial of Selegiline Transdermal System (STS) as an Aid for Smoking Cessation.

Last checked: Nov 20, 2026Latest source record: Feb 2, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 246 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

246

Actual

Start

Jun 2007

Primary completion

Aug 2008

Study completion Jan 2009

Sponsor

Sponsor type
NIH
Collaborators
VA Office of Research and Development
First posted
Feb 23, 2007

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 99 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is designed to examine the effects of Selegiline Transdermal System and behavioral intervention in smoking cessation as compared to behavioral intervention alone.

Conditions

  • Nicotine Dependence

Interventions

  • Selegiline Transdermal PatchDrug

    Selegiline cm(2) via transdermal system

  • PlaceboDrug

    Matching placebo via transdermal system

  • Smoking Cessation CounselingBehavioral

    Subjects were provided with on-site, individual smoking cessation counseling sessions 1x per week for 9 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Quit RateTime frame: Study weeks 6 through 9

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Department of Public & Community Health

    College Park, Maryland

  • Robert Wood Johnson Med School-Tobacco Dep Program

    New Brunswick, New Jersey

  • Tri-State Tobacco and Alcohol Research Center

    Cincinnati, Ohio

  • Center For Tobacco Research and Intervention

    Milwaukee, Wisconsin

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.